Antivenom, also known as antivenin, venom antiserum, and antivenom immunoglobulin, is a specific treatment for envenomation. It is composed of antibodies and used to treat certain venomous bites and stings. Antivenoms are recommended only if there is significant toxicity or a high risk of toxicity.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Anti-Venom industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Polyvalent Antivenom
Monovalent Antivenom
Market Segment by Product Application
Retail Pharmacies
Hospitals
Others
Finally, the report provides detailed profile and data information analysis of leading company.
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Anti-Venom consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Anti-Venom market by identifying its various subsegments.
3.Focuses on the key global Anti-Venom manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Anti-Venom with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Anti-Venom submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Anti-Venom Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Anti-Venom Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Anti-Venom Segment by Type
2.1.1 Polyvalent Antivenom
2.1.2 Monovalent Antivenom
2.2 Market Analysis by Application
2.2.1 Retail Pharmacies
2.2.2 Hospitals
2.2.3 Others
2.3 Global Anti-Venom Market Comparison by Regions (2017-2027)
2.3.1 Global Anti-Venom Market Size (2017-2027)
2.3.2 North America Anti-Venom Status and Prospect (2017-2027)
2.3.3 Europe Anti-Venom Status and Prospect (2017-2027)
2.3.4 China Anti-Venom Status and Prospect (2017-2027)
2.3.5 Japan Anti-Venom Status and Prospect (2017-2027)
2.3.6 Southeast Asia Anti-Venom Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Anti-Venom Industry Impact
2.5.1 Anti-Venom Business Impact Assessment - Covid-19
2.5.2 Market Trends and Anti-Venom Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Anti-Venom Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Anti-Venom Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Anti-Venom Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Anti-Venom Manufacturer Market Share
3.5 Top 10 Anti-Venom Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Anti-Venom Market
3.7 Key Manufacturers Anti-Venom Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Anti-Venom Industry Key Manufacturers
4.1 CSL Behring
4.1.1 Compan Detail
4.1.2 CSL Behring Anti-Venom Product Introduction, Application and Specification
4.1.3 CSL Behring 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 CSL Behring News
4.2 Merck & Co.
4.2.1 Compan Detail
4.2.2 Merck & Co. Anti-Venom Product Introduction, Application and Specification
4.2.3 Merck & Co. Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 CSL Behring News
4.3 BTG Plc
4.3.1 Compan Detail
4.3.2 BTG Plc Anti-Venom Product Introduction, Application and Specification
4.3.3 BTG Plc Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 BTG Plc News
4.4 Pfizer
4.4.1 Compan Detail
4.4.2 Pfizer Anti-Venom Product Introduction, Application and Specification
4.4.3 Pfizer Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Pfizer News
4.5 Haffkine Bio-Pharmaceutical Corporation
4.5.1 Compan Detail
4.5.2 Pfizer Anti-Venom Product Introduction, Application and Specification
4.5.3 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Haffkine Bio-Pharmaceutical Corporation News
4.6 Rare Disease Therapeutics
4.6.1 Compan Detail
4.6.2 Rare Disease Therapeutics Anti-Venom Product Introduction, Application and Specification
4.6.3 Rare Disease Therapeutics Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Rare Disease Therapeutics News
4.7 Flynn Pharma
4.7.1 Compan Detail
4.7.2 Flynn Pharma Anti-Venom Product Introduction, Application and Specification
4.7.3 Flynn Pharma Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Vins Bioproducts
4.8.1 Compan Detail
4.8.2 Vins Bioproducts Anti-Venom Product Introduction, Application and Specification
4.8.3 Vins Bioproducts Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Vins Bioproducts News
4.9 Bharat Serums and Vaccines
4.9.1 Compan Detail
4.9.2 Bharat Serums and Vaccines Anti-Venom Product Introduction, Application and Specification
4.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bharat Serums and Vaccines News
4.10 Serum Biotech
4.10.1 Compan Detail
4.10.2 Serum Biotech Anti-Venom Product Introduction, Application and Specification
4.10.3 Serum Biotech Anti-Venom Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Serum Biotech News
5 Global Anti-Venom Market Segment by Big Type
5.1 Global Anti-Venom Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Anti-Venom Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Anti-Venom Revenue and Market Share by Big Type (2017-2022)
5.2 Polyvalent Antivenom Sales Growth Rate and Price
5.2.1 Global Polyvalent Antivenom Sales Growth Rate (2017-2022)
5.2.2 Global Polyvalent Antivenom Price (2017-2022)
5.3 Monovalent Antivenom Sales Growth Rate and Price
5.3.1 Global Monovalent Antivenom Sales Growth Rate (2017-2022)
5.3.2 Global Monovalent Antivenom Price (2017-2022)
6 Global Anti-Venom Market Segment by Big Application
6.1 Global Anti-Venom Sales Market Share by Big Application (2017-2022)
6.2 Retail Pharmacies Sales Growth Rate (2017-2022)
6.3 Hospitals Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Anti-Venom Forecast
7.1 Global Anti-Venom Revenue, Sales and Growth Rate (2022-2027)
7.2 Anti-Venom Market Forecast by Regions (2022-2027)
7.2.1 North America Anti-Venom Market Forecast (2022-2027)
7.2.2 Europe Anti-Venom Market Forecast (2022-2027)
7.2.3 China Anti-Venom Market Forecast (2022-2027)
7.2.4 Japan Anti-Venom Market Forecast (2022-2027)
7.2.5 Southeast Asia Anti-Venom Market Forecast (2022-2027)
7.2.6 Other Regions Anti-Venom Market Forecast (2022-2027)
7.3 Anti-Venom Market Forecast by Type (2022-2027)
7.3.1 Global Anti-Venom Sales Forecast by Type (2022-2027)
7.3.2 Global Anti-Venom Market Share Forecast by Type (2022-2027)
7.4 Anti-Venom Market Forecast by Application (2022-2027)
7.4.1 Global Anti-Venom Sales Forecast by Application (2022-2027)
7.4.2 Global Anti-Venom Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Anti-Venom Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Anti-Venom Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Anti-Venom
Figure Market Concentration Ratio and Market Maturity Analysis of Anti-Venom
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Anti-Venom Market Size by Big Type
Figure Global Market Share of Anti-Venom by Big Type in 2021
Figure Polyvalent Antivenom Picture (2017-2022)
Global Anti-Venom Market Size by Big Application
Table Global Anti-Venom Market Size by Application
Figure Global Anti-Venom Market Share by Big Application in 2021
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Table Global Anti-Venom Comparison by Regions (M USD) (2017-2027)
Figure Global Anti-Venom Market Size (Million US$) (2017-2027)
Figure North America Anti-Venom Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Anti-Venom Revenue (Million US$) Growth Rate (2017-2027)
Figure China Anti-Venom Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Anti-Venom Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Anti-Venom Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Anti-Venom Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Anti-Venom Sales by Manufacturer (2017-2022)
Figure Global Anti-Venom Sales Market Share by Manufacturer in 2021
Table Global Anti-Venom Revenue by Manufacturer (2017-2022)
Figure Global Anti-Venom Revenue Market Share by Manufacturer in 2021
Table Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Anti-Venom Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Anti-Venom Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Anti-Venom Market
Table Key Manufacturers Anti-Venom Product Type
Table Mergers & Acquisitions Planning
Table CSL Behring Company Profile
Table Anti-Venom Product Introduction, Application and Specification of CSL Behring
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Merck & Co. Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Merck & Co.
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Recent Development
Table BTG Plc Company Profile
Table Anti-Venom Product Introduction, Application and Specification of BTG Plc
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BTG Plc Main Business
Table BTG Plc Recent Development
Table Pfizer Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Pfizer
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Pfizer Main Business
Table Pfizer Recent Development
Table Haffkine Bio-Pharmaceutical Corporation Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Haffkine Bio-Pharmaceutical Corporation
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Haffkine Bio-Pharmaceutical Corporation Main Business
Table Haffkine Bio-Pharmaceutical Corporation Recent Development
Table Rare Disease Therapeutics Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Rare Disease Therapeutics
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Rare Disease Therapeutics Main Business
Table Rare Disease Therapeutics Recent Development
Table Flynn Pharma Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Flynn Pharma
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Flynn Pharma Main Business
Table Flynn Pharma Recent Development
Table Vins Bioproducts Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Vins Bioproducts
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Vins Bioproducts Main Business
Table Vins Bioproducts Recent Development
Table Bharat Serums and Vaccines Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Bharat Serums and Vaccines
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bharat Serums and Vaccines Main Business
Table Bharat Serums and Vaccines Recent Development
Table Serum Biotech Company Profile
Table Anti-Venom Product Introduction, Application and Specification of Serum Biotech
Table Anti-Venom Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Serum Biotech Main Business
Table Serum Biotech Recent Development
Figure Global Anti-Venom Sales and Growth Rate (2017-2022)
Figure Global Anti-Venom Revenue and Growth Rate (2017-2022)
Table Global Anti-Venom Sales by Regions (2017-2022)
Figure Global Anti-Venom Sales Market Share by Regions in 2021
Table Global Anti-Venom Revenue by Regions (2017-2022)
Figure Global Anti-Venom Revenue Market Share by Regions in 2021
Figure North America Anti-Venom Sales and Growth Rate (2017-2022)
Figure Europe Anti-Venom Sales and Growth Rate (2017-2022)
Figure China Anti-Venom Sales and Growth Rate (2017-2022)
Figure Japan Anti-Venom Sales and Growth Rate (2017-2022)
Figure Southeast Asia Anti-Venom Sales and Growth Rate (2017-2022)
Figure Other Regions Anti-Venom Sales and Growth Rate (2017-2022)
Table Global Anti-Venom Sales by Big Type (2017-2022)
Table Global Anti-Venom Sales Market Share by Big Type (2017-2022)
Figure Global Anti-Venom Sales Market Share by Big Type in 2019
Table Global Anti-Venom Revenue by Big Type (2017-2022)
Table Global Anti-Venom Revenue Market Share by Big Type (2017-2022)
Table Global Anti-Venom Revenue Market Share by Big Type in 2019
Figure Global Polyvalent Antivenom Sales Growth Rate (2017-2022)
Figure Global Polyvalent Antivenom Price (2017-2022)
Figure Global Monovalent Antivenom Sales Growth Rate (2017-2022)
Table Global Anti-Venom Sales by Big Application (2017-2022)
Table Global Anti-Venom Sales Market Share by Big Application (2017-2022)
Figure Global Anti-Venom Sales Market Share by Big Application in 2019
Figure Global Retail Pharmacies Sales Growth Rate (2017-2022)
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Anti-Venom Sales and Growth Rate (2022-2027)
Figure Global Anti-Venom Revenue and Growth Rate (2022-2027)
Table Global Anti-Venom Sales Forecast by Regions (2022-2027)
Table Global Anti-Venom Market Share Forecast by Regions (2022-2027)
Figure North America Sales Anti-Venom Market Forecast (2022-2027)
Figure Europe Sales Anti-Venom Market Forecast (2022-2027)
Figure China Sales Anti-Venom Market Forecast (2022-2027)
Figure Japan Sales Anti-Venom Market Forecast (2022-2027)
Figure Southeast Asia Sales Anti-Venom Market Forecast (2022-2027)
Figure Other Regions Sales Anti-Venom Market Forecast (2022-2027)
Table Global Anti-Venom Sales Forecast by Type (2022-2027)
Table Global Anti-Venom Market Share Forecast by Type (2022-2027)
Table Global Anti-Venom Sales Forecast by Application (2022-2027)
Table Global Anti-Venom Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Venom
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Anti-Venom Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Anti-Venom Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Anti-Venom Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Anti-Venom Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Anti-Venom Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Anti-Venom Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Anti-Venom Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Anti-Venom Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)